STTK (Shattuck Labs, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Shattuck Labs, Inc. Common Stock (STTK) is a publicly traded Healthcare sector company. As of May 21, 2026, STTK trades at $6.29 with a market cap of $457.78M and a P/E ratio of -10.20. STTK moved +6.82% today. Year to date, STTK is +58.61%; over the trailing twelve months it is +499.03%. Its 52-week range spans $0.69 to $8.33. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces STTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns STTK stock?
Hedge funds tracked by Rallies that own STTK include Orbimed Advisors and Redmile Group. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Shattuck Labs, Inc. Common Stock.
STTK Key Metrics
Key financial metrics for STTK
Metric
Value
Price
$6.29
Market Cap
$457.78M
P/E Ratio
-10.20
EPS
$-0.59
Dividend Yield
0.00%
52-Week High
$8.33
52-Week Low
$0.69
Volume
279.60K
Avg Volume
0
Revenue (TTM)
$1.00M
Net Income
$-49.87M
Gross Margin
0.00%
Top Hedge Funds Holding STTK
Orbimed Advisors holds 6.31M shares of STTK, changed +0.00% as of Mar 31, 2026.
Redmile Group holds 5.54M shares of STTK, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own STTK include Orbimed Advisors and Redmile Group. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Shattuck Labs, Inc. Common Stock.
Does Rallies show 13F holders for STTK?
Yes. Rallies tracks hedge fund and 13F ownership data for STTK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is STTK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STTK. It does not provide personalized investment advice.